Cytrx Corp (CYTR)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0920 unch (unch) 10/05/22 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0920 unch (unch) -
for Wed, Oct 5th, 2022
Results
download Want to compare other data? Select Fields| Symbol | CYTR | ALBT | CELZ | ||
| Company | Cytrx Corp | Avalon Globocare | Creative Medical Technology Holdings Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.0922 | 4.80 | 2.27 | ||
| High | 0.1000 | 4.91 | 2.34 | ||
| Low | 0.0900 | 3.82 | 2.10 | ||
| Last | 0.0920 | 3.90 | 2.31 | ||
| Change | unch | -0.90 | +0.07 | ||
| % Change | unch | -18.75% | +3.12% | ||
| Volume | 4,000 | 55,800 | 53,500 | ||
| 20-Day Average Volume | 52,605 | 47,560 | 122,710 | ||
| Previous Close | 0.0920 | 4.80 | 2.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1037 | 5.22 | 2.74 | ||
| 20-Day Raw Stochastic | 32.20% | 1.97% | 16.60% | ||
| 20-Day Relative Strength | 47.54% | 42.41% | 40.28% | ||
| Weighted Alpha | -82.94 | -59.41 | -65.79 | ||
| Today's Opinion | 72% Sell | 24% Sell | 56% Sell | ||
| Previous Opinion | 72% Sell | 48% Buy | 56% Sell | ||
| Last Month's Opinion | 100% Sell | 72% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.88% since 09/28/22 | -26.00% since 03/28/25 | +1.76% since 03/28/25 | ||
| Low | 0.0730 on 09/29/22 | 3.82 on 04/04/25 | 1.95 on 04/01/25 | ||
| High | 0.1010 on 10/04/22 | 5.28 on 03/31/25 | 2.34 on 04/04/25 | ||
| 1-Month | |||||
| %Chg | +16.16% since 09/02/22 | -63.52% since 03/04/25 | -61.44% since 03/04/25 | ||
| Low | 0.0710 on 09/06/22 | 3.82 on 04/04/25 | 1.92 on 03/26/25 | ||
| High | 0.1320 on 09/20/22 | 11.60 on 03/06/25 | 6.75 on 03/05/25 | ||
| 3-Month | |||||
| %Chg | -3.16% since 07/05/22 | +6.56% since 01/03/25 | -5.33% since 01/03/25 | ||
| Low | 0.0616 on 08/25/22 | 3.20 on 01/14/25 | 1.92 on 03/26/25 | ||
| High | 0.1320 on 09/20/22 | 11.66 on 03/04/25 | 6.90 on 02/20/25 | ||
| 6-Month | |||||
| %Chg | -68.28% since 04/05/22 | +21.67% since 10/04/24 | -23.00% since 10/04/24 | ||
| Low | 0.0521 on 06/29/22 | 2.11 on 11/04/24 | 1.92 on 03/26/25 | ||
| High | 0.3048 on 04/06/22 | 11.66 on 03/04/25 | 6.90 on 02/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,143 | 4,267 | 4,039 | ||
| Shares Outstanding, K | 45,037 | 1,094 | 1,748 | ||
| Annual Sales | 0 | 1,260,000 | 10,000 | ||
| Annual Net Income | -13,180,000 | -16,710,000 | -5,490,000 | ||
| Last Quarter Sales | N/A | 350,000 | 0 | ||
| Last Quarter Net Income | N/A | -1,680,000 | -1,040,000 | ||
| 60-Month Beta | 1.82 | 0.16 | 2.00 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 08/11/22 | -1.82 on 11/12/24 | -1.12 on 03/14/25 | ||
| Latest Earnings Date | 11/11/22 | 05/29/25 | 05/09/25 | ||
| Most Recent Dividend | 0.249 on 03/07/08 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||